17 June 2024
SEEEN plc
("SEEEN", the "Group" or the "Company")
Result of General Meeting
and
Total Voting Rights
SEEEN plc (AIM: SEEN), the media and technology platform that delivers Key Video Moments to drive increased views and revenues across video content, announces the results of the voting on the Resolutions put to its General Meeting held earlier today. All Resolutions put to Shareholders at the meeting were duly passed.
Total Voting Rights
Pursuant to its Fundraise to raise a total of approximately £763,000, details of which were announced on 31 May 2024, the Company has applied for Admission of the Second Fundraise Shares to trading on AIM ("Second Admission"). Second Admission is anticipated to occur at 8.00 a.m. on 19 June 2024.
Following Second Admission, the Company's issued ordinary share capital will consist of 118,779,141 Ordinary Shares with one voting right per Ordinary Share. The Company does not hold any Ordinary Shares in treasury. Therefore, following Second Admission, the total number of Ordinary Shares and voting rights in the Company will be 118,779,141. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.
Director and significant shareholdings
Following Second Admission, the revised holdings of the Directors who are interested in the Company's Ordinary Shares will be as set out in the table below:
| Name | Board role | Number of Subscription Shares | Total number of Ordinary Shares held following Second Admission | % of enlarged ordinary share capital following Second Admission |
| Dr Patrick DeSouza | Non-Executive Chairman | 2,000,000 | 7,426,164* | 6.25%* |
| Adrian Hargrave | Chief Executive Officer | 933,333 | 1,985,747 | 1.67% |
| David Anton | Non-Executive Director | 1,333,333 | 1,333,333 | 1.12% |
| Mark Williams | Non-Executive Director | 333,333 | 333,333 | 0.28% |
* This includes Ordinary Shares held directly and the interest of a related trust, of which Dr DeSouza's immediate family are the sole beneficiaries. Dr DeSouza is the trustee of the trust.
In addition, as a result of the issue of the Second Fundraise Shares, the Company is aware of the following interests of certain significant shareholders (as defined in the AIM Rules for Companies) in the Company, which will be revised following Admission:
| Name | Number of Ordinary Shares held following Second Admission | Percentage of enlarged share capital following Second Admission | ||
| Water Intelligence plc** | 5,938,366 | 5.00% | ||
| | | | ||
** Dr DeSouza is a director of Water Intelligence plc and Dr DeSouza is interested in 25% of Water Intelligence plc's issued share capital.
Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the announcement made by the Company at 07:00 on 31 May 2024.
For further information please contact:
| SEEEN, seeen.com | Tel: +44 (0)7775 701 838 |
| Adrian Hargrave, CEO | |
| | |
| Dowgate Capital (Joint Broker) | Tel: +44 (0)20 3903 7721 |
| Stephen Norcross | |
| | |
| Capital Plus Partners Ltd (Joint Broker) | Tel: +44 (0)203 821 6167 |
| Jonathan Critchley / Jon Levinson | |
| | |
| Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: +44 (0)20 3328 5656 |
| Alex Brearley / George Payne / Lauren Wright (Corporate Finance) Tony Quirke / Amrit Nahal (Sales and Corporate Broking) | |
| Focus IR (Investor Relations) | Tel: +44(0)7866 384 707 |
| Paul Cornelius / Kat Perez | seeen@focusir.com |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.